Ming-Huang Chen

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 9

Top Topics

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, Chin-Fu Hsiao, Chung-Yu Huang, Yi-Ping Hung, Chien-Jui Huang, San-Chi Chen, Yan-Shen Shan, Yee Chao, Yi-Hsiang Huang, I-Cheng Lee, Pei-Chang Lee, Yung-Yeh Su, Shu-Jen Chen, Chun-Nan Yeh, Li-Tzong Chen, Ming-Huang Chen
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Kien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, Jen-Hao Cheng, Wen-Liang Fang, Yi-Chen Yeh, Yu-Chao Wang, Dennis Shin-Shian Hsu, Chiao-En Wu, Jiun-I Lai, Peter Mu-Hsin Chang, Ming-Han Chen, Meng-Lun Lu, Shu-Jen Chen, Yee Chao, Michael Hsiao, Ming-Huang Chen
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy. Journal for immunotherapy of cancer 8 (1) (2021)
Ming-Huang Chen, Sheng-Nan Lu, Chien-Hung Chen, Peng-Chan Lin, Jeng-Kai Jiang, Yulia D'yachkova, Mariusz Lukanowski, Rebecca Cheng, Li-Tzong Chen
How May Ramucirumab Help Improve Treatment Outcome for Patients with Gastrointestinal Cancers? Cancers 13 (14) (2021)
Pei-Chang Lee, Yee Chao, Ming-Huang Chen, Keng-Hsin Lan, I-Cheng Lee, Ming-Chih Hou, Yi-Hsiang Huang
Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. Journal for immunotherapy of cancer 8 (2) (2021)
Nai-Jung Chiang, Li-Tzong Chen, Yan-Shen Shan, Chun-Nan Yeh, Ming-Huang Chen
Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials. Biomolecules 11 (1) (2021)
Chiao-En Wu, Da-Wei Yeh, Yi-Ru Pan, Wen-Kuan Huang, Ming-Huang Chen, John Wen-Cheng Chang, Jen-Shi Chen, Yu-Chao Wang, Chun-Nan Yeh
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis. Life (Basel, Switzerland) 10 (11) (2020)
Michael Hsiao, Ming-Huang Chen, Chun-Nan Yeh, Michael Hsiao
Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma. Biomolecules 10 (10) (2020)
Pei-Chang Lee, Yee Chao, Ming-Huang Chen, Keng-Hsin Lan, Chieh-Ju Lee, I-Cheng Lee, San-Chi Chen, Ming-Chih Hou, Yi-Hsiang Huang
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma. Cancers 12 (1) (2020)
Chiao-En Wu, Ming-Huang Chen, Chun-Nan Yeh
mTOR Inhibitors in Advanced Biliary Tract Cancers. International journal of molecular sciences 20 (3) (2019)